Rocepafant

CAS No. 132579-32-9

Rocepafant( —— )

Catalog No. M34402 CAS No. 132579-32-9

Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 116 Get Quote
5MG 168 Get Quote
10MG 247 Get Quote
25MG 466 Get Quote
50MG 635 Get Quote
100MG 884 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rocepafant
  • Note
    Research use only, not for human use.
  • Brief Description
    Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.
  • Description
    Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.Rocepafant inhibits tumor necrosis factor-Afa-mediated cytotoxicity in mouse L929 tumor cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Platelet aggregation
  • Recptor
    Platelet aggregation
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    132579-32-9
  • Formula Weight
    535.08
  • Molecular Formula
    C26H23ClN6OS2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1N2C3=C(C4=C(S3)CN(C(NC5=CC=C(OC)C=C5)=S)CC4)C(=NCC2=NN1)C6=C(Cl)C=CC=C6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DF-1111301

    DF-1111301 is a novel anti-allergic compound with anti-histamine H1 and anti-PAF activity.

  • Suloctidil

    Suloctidil is a new drug that is currently being evaluated in many clinical trials for use in dementia and thrombotic disorders.

  • Veratrosine

    Veratrosine is an alkaloid isolated from the herbs of Veratrum nigrum. Veratrosine exhibits feeble inhibition activity against platelet aggregation.